@article{Al-Azri_Manarang_Al-Mufargi_2017, title={Bacille Calmette-Guérin Vaccine-Induced Tuberculous Hip Osteomyelitis in an Infant : Case report}, volume={17}, url={https://journals.squ.edu.om/index.php/squmj/article/view/2239}, DOI={10.18295/squmj.2017.17.03.019}, abstractNote={<span>To this day, tuberculosis (TB) continues to pose a significant global health burden. The World Health Organization’s Expanded Programme on Immunization (EPI) recommends the </span><span>bacille</span><span> Calmette-Guérin (BCG) vaccine for infants to protect against the haematogenous spread of primary TB and other more severe types of TB infection. We report an eight-month-old boy who presented to the Armed Forces Hospital, Muscat, Oman, in 2015 with a one-month history of intermittent fever associated with a limited range of motion in the right hip area. He was up-to-date with his EPI vaccinations and had no history of exposure to individuals with TB infections. He was initially treated for bacterial septic arthritis; however, a GeneXpert TB assay revealed the presence of </span><span>Mycobacterium tuberculosis</span><span>, BCG strain. To the best of the authors’ knowledge, this is the first documented case from Oman of a child with TB hip osteomyelitis due to a BCG vaccination.</span><br /><br /><br />}, number={3}, journal={Sultan Qaboos University Medical Journal}, author={Al-Azri, Mohammed S. and Manarang, Jazel and Al-Mufargi, Yaqoub}, year={2017}, month={Aug.}, pages={358–362} }